Companies › The STARR Coalition

The STARR Coalition

Trade or professional group Healthcare

The STARR Coalition is listed as a trade or professional group in Healthcare. It has filed 3 comment letters on 3 proposed federal rules in 2026, most often with the Drug Enforcement Administration.

Type
Trade or professional group
Industry
Healthcare
Comment letters
3
Rules commented on
3
First letter
2026-07-01
Latest letter
2026-10-09
Agencies most often
Drug Enforcement Administration (1); Centers for Medicare & Medicaid Services (1); Office of Inspector General (1)

Activity by year

20263

Letters

2026

Schedules of Controlled Substances: Placement of 4-Hydroxy-N,N-Diisopropyltryptamine (4-OH-DiPT), 5-Methoxy-alpha-Methyltryptamine (5-MeO-AMT), 5-Methoxy-N-Methyl-N-Isopropyltryptamine (5-MeO-MiPT), 5-Methoxy-N,N-Diethyltryptamine (5-MeO-DET), and N,N-Diisopropyltryptamine (DiPT) Into Schedule I

DEA-2026-1585Justice Department, Drug Enforcement Administration · filed 2026-10-09

Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program

CMS-2026-2080Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2026-09-02

Medicare and State Health Care Programs: Fraud and Abuse; Request for Information Regarding the Federal Anti-Kickback Statute and Beneficiary Inducements CMP

HHSIG-2026-0034Health and Human Services Department, Office of Inspector General · filed 2026-07-01